πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Patent portfolio

NORTHWEST BIOTHERAPEUTICS Patents

Full USPTO pharma patent portfolio for NORTHWEST BIOTHERAPEUTICS β€” grant dates, expiration, and drug cross-links.

Patents
595
Expiring ≀24m
13

Quick answer

NORTHWEST BIOTHERAPEUTICS has 595 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 13 expire within 24 months β€” use filters for patent-cliff planning.

Page 11 of 13

  1. US 8158627

    Compositions and treatments using pyridazine compounds and cholinesterase inhibitors

    Expires Mon Apr 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8158658

    Heteroaromatic selective inhibitors of neuronal nitric oxide synthase

    Expires Mon Apr 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8138140

    Self-assembling peptide amphiphiles and related methods for growth factor delivery

    Expires Mon Mar 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8128930

    Anti-ADDL antibodies and uses thereof

    Expires Mon Mar 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8124583

    Composition and method for self-assembly and mineralization of peptide-amphiphiles

    Expires Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8114834

    Self-assembling peptide amphiphiles

    Expires Mon Feb 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8114830

    Polypeptoid pulmonary surfactants

    Expires Mon Feb 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8114835

    Self-assembling peptide amphiphiles for tissue engineering

    Expires Mon Feb 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8088774

    Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death

    Expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8080262

    Encapsulated peptide amphiphile nanostructures

    Expires Mon Dec 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8063014

    Self-assembly of peptide-amphiphile nanofibers under physiological conditions

    Expires Mon Nov 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8063047

    Pyridazine compounds and methods

    Expires Mon Nov 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8058244

    Cyclic peptide antitumor agents

    Expires Mon Nov 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8048415

    Compositions and methods for promoting or inhibiting angiogenesis

    Expires Mon Oct 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8021646

    Compositions and methods for magnetic resonance imaging contrast agents

    Expires Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8008021

    N-terminal truncation of cardiac troponin subunits and their roles in cardiovascular disease

    Expires Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7994326

    Potent and highly selective heteroaromatic inhibitors of neuronal nitric oxide synthase

    Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7973075

    Kainate receptor-selective epimeric analogs of dysiherbaine

    Expires Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7951770

    Peptides, peptidomimetics and small molecule inhibitors of the Epstein-Barr virus mediated fusion and entry process

    Expires Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7928129

    Nanomolar Ξ²-lactamase inhibitors

    Expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7919485

    Protein kinase targeted therapeutics

    Expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7888357

    Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death

    Expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7851445

    Angiogenic heparin-binding epitopes, peptide amphiphiles, self-assembled compositions and related methods of use

    Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7846466

    Biodegradable scaffolds and uses thereof

    Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7838491

    Self-assembly and mineralization of peptide-amphiphile nanofibers

    Expires Mon Nov 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7829304

    Compounds and related methods for mutant p53 reactivation

    Expires Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7811563

    Anti-addl antibodies and uses thereof

    Expires Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7807393

    Biomarkers for prostate cancer

    Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7790039

    Tangential flow filtration devices and methods for stem cell enrichment

    Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7780963

    Anti-ADDL antibodies and uses thereof

    Expires Mon Aug 19 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7767717

    Treatment and prevention of excessive scarring with 4-hydroxy tamoxifen

    Expires Mon Jul 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7745708

    Self-assembly of peptide-amphiphile nanofibers under physiological conditions

    Expires Mon Jun 24 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7732445

    Myosin light chain kinase inhibitor compounds, compostions and related methods of use

    Expires Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7723313

    Methods and compositions for inhibiting angiogenesis

    Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7709443

    Cyclic peptide antitumor agents

    Expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7695627

    Tangential flow filtration devices and methods for leukocyte enrichment

    Expires Mon Apr 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7638283

    Amyloid Ξ² protein (globular assembly and uses thereof)

    Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7629323

    Manipulation of neuronal ion channels

    Expires Mon Dec 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7618986

    Method of treating latent tuberculosis

    Expires Mon Nov 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7604798

    Methods and compositions for importing nucleic acids into cell nuclei

    Expires Mon Oct 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7601355

    Compositions and methods for altering immune function

    Expires Mon Oct 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7595047

    Compositions and methods for promoting or inhibiting angiogenesis

    Expires Mon Sep 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7569340

    Nanoarrays of single virus particles, methods and instrumentation for the fabrication and use thereof

    Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7554021

    Composition and method for self-assembly and mineralization of peptide amphiphiles

    Expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7544661

    Self-assembling peptide amphiphiles and related methods for growth factor delivery

    Expires Mon Jun 04 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7541381

    Non-covalent inhibitors of AmpC Ξ²-lactamase

    Expires Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7534761

    Charged peptide-amphiphile solutions and self-assembled peptide nanofiber networks formed therefrom

    Expires Mon May 14 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7491690

    Self-assembly and mineralization of peptide-amphiphile nanofibers

    Expires Mon Feb 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does NORTHWEST BIOTHERAPEUTICS have?

595 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do NORTHWEST BIOTHERAPEUTICS patents expire?

13 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.